Document Detail


Carboxylic acid (bio)isosteres in drug design.
MedLine Citation:
PMID:  23361977     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The carboxylic acid functional group can be an important constituent of a pharmacophore, however, the presence of this moiety can also be responsible for significant drawbacks, including metabolic instability, toxicity, as well as limited passive diffusion across biological membranes. To avoid some of these shortcomings while retaining the desired attributes of the carboxylic acid moiety, medicinal chemists often investigate the use of carboxylic acid (bio)isosteres. The same type of strategy can also be effective for a variety other purposes, for example, to increase the selectivity of a biologically active compound or to create new intellectual property. Several carboxylic acid isosteres have been reported, however, the outcome of any isosteric replacement cannot be readily predicted as this strategy is generally found to be dependent upon the particular context (i.e., the characteristic properties of the drug and the drug-target). As a result, screening of a panel of isosteres is typically required. In this context, the discovery and development of novel carboxylic acid surrogates that could complement the existing palette of isosteres remains an important area of research. The goal of this Minireview is to provide an overview of the most commonly employed carboxylic acid (bio)isosteres and to present representative examples demonstrating the use and utility of each isostere in drug design.
Authors:
Carlo Ballatore; Donna M Huryn; Amos B Smith
Related Documents :
24333867 - A 3-week dietary bioequivalence study in preweaning farm piglets of two sources of doco...
23663357 - The incidence and magnitude of fibrinolytic activation in trauma patients: a reply to a...
23340907 - New insights into prebiotic chemistry from stanley miller's spark discharge experiments.
23254727 - Upper face rejuvenation using botulinum toxin and hyaluronic acid fillers.
16599547 - Measurement and analysis of intracellular atp levels in metabolically engineered zymomo...
6430017 - The effects of carbamazepine and valproate on folate metabolism in man.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review     Date:  2013-01-29
Journal Detail:
Title:  ChemMedChem     Volume:  8     ISSN:  1860-7187     ISO Abbreviation:  ChemMedChem     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-02-25     Completed Date:  2013-08-30     Revised Date:  2014-03-06    
Medline Journal Info:
Nlm Unique ID:  101259013     Medline TA:  ChemMedChem     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  385-95     Citation Subset:  IM    
Copyright Information:
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Azoles / chemistry,  metabolism
Carboxylic Acids / chemistry*,  metabolism
Drug Design*
Furans / chemistry,  metabolism
Hydroxamic Acids / chemistry,  metabolism
Ketones / chemistry,  metabolism
Kinetics
Phosphorous Acids / chemistry,  metabolism
Sulfonamides / chemistry,  metabolism
Sulfonic Acids / chemistry,  metabolism
Grant Support
ID/Acronym/Agency:
AG034140/AG/NIA NIH HHS; R01 AG034140/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
0/Azoles; 0/Carboxylic Acids; 0/Furans; 0/Hydroxamic Acids; 0/Ketones; 0/Phosphorous Acids; 0/Sulfonamides; 0/Sulfonic Acids; 13598-36-2/phosphonic acid; 4971-56-6/tetronic acid
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A novel neurofibromin (NF1) interaction with the leucine-rich pentatricopeptide repeat motif-contain...
Next Document:  Predictive models for cellular signaling networks.